Engine Bio Hires Stephen Harrison as Chief Scientific Officer

Drug discovery startup Engine Biosciences has named Stephen Harrison chief scientific officer and senior vice president of the San Francisco company. Harrison most recently worked at Relypsa in Redwood City, CA, where he was chief scientific officer. His experience also includes positions at Nektar Therapeutics (NASDAQ: [[ticker:NKTR]]), KAI Pharmaceuticals, Chiron, and Thios. Engine Biosciences, which uses artificial intelligence to discover new drugs, raised $10 million in financing in January to continue to develop its technology.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.